FDA appears to be slow-walking vaccine approvals The Covid vaccine from Novavax was expected to be approved earlier this month. Now, the FDA is requiring the company to complete a new clinical trial.
https://cdn.masto.host/medmastodoncom/media_attachments/files/114/530/601/486/165/733/original/36914c24c699823c.png